Literature DB >> 27542860

A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal Masses.

Hiten D Patel1, Emmanuel Iyoha2, Phillip M Pierorazio3, Stephen M Sozio4, Michael H Johnson3, Ritu Sharma2, Eric B Bass2, Mohamad E Allaf3.   

Abstract

The management of clinically localized renal masses suspicious for renal cell carcinoma varies, partially because of gaps in the evidence base. We conducted a systematic review to summarize research gaps for the evaluation of composite models for predicting malignancy; use of percutaneous renal sampling for diagnosis; and comparative effectiveness of surgery, thermal ablation, and active surveillance. A total of 147 studies, published in 150 articles, were identified. To promote improved patient care and health outcomes, we recommend incorporation of emerging biomarkers into validated composite models, standardization of biopsy protocols, standard reporting of clinical stage, and performance of prospective studies with objective selection criteria.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27542860      PMCID: PMC5598464          DOI: 10.1016/j.urology.2016.08.013

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  23 in total

1.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

2.  Who really benefits from nephron-sparing surgery?

Authors:  Solomon L Woldu; Aaron C Weinberg; Ruslan Korets; Rashed Ghandour; Matthew R Danzig; Arindam RoyChoudhury; Sean D Kalloo; Mitchell C Benson; G Joel DeCastro; James M McKiernan
Journal:  Urology       Date:  2014-10       Impact factor: 2.649

3.  External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses.

Authors:  Kyo Chul Koo; Hanna Yoo; Tae Young Shin; Jongchan Kim; Young Deuk Choi; Koon Ho Rha; Won Sik Ham
Journal:  World J Urol       Date:  2013-09-07       Impact factor: 4.226

Review 4.  Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.

Authors:  Phillip M Pierorazio; Michael H Johnson; Hiten D Patel; Stephen M Sozio; Ritu Sharma; Emmanuel Iyoha; Eric B Bass; Mohamad E Allaf
Journal:  J Urol       Date:  2016-05-06       Impact factor: 7.450

5.  Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.

Authors:  Alexander Kutikov; Marc C Smaldone; Brian L Egleston; Brandon J Manley; Daniel J Canter; Jay Simhan; Stephen A Boorjian; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Robert G Uzzo
Journal:  Eur Urol       Date:  2011-04-01       Impact factor: 20.096

6.  Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.

Authors:  Michael A Gorin; Steven P Rowe; Alexander S Baras; Lilja B Solnes; Mark W Ball; Phillip M Pierorazio; Christian P Pavlovich; Jonathan I Epstein; Mehrbod S Javadi; Mohamad E Allaf
Journal:  Eur Urol       Date:  2015-09-18       Impact factor: 20.096

7.  Renal cell cancer stage migration: analysis of the National Cancer Data Base.

Authors:  Christopher J Kane; Katherine Mallin; Jamie Ritchey; Matthew R Cooperberg; Peter R Carroll
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

8.  Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management.

Authors:  Hiten D Patel; Max Kates; Phillip M Pierorazio; Elias S Hyams; Michael A Gorin; Mark W Ball; Sam B Bhayani; Xuan Hui; Carol B Thompson; Mohamad E Allaf
Journal:  Urology       Date:  2013-11-16       Impact factor: 2.649

9.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

10.  Diagnostic randomized controlled trials: the final frontier.

Authors:  Marc Rodger; Tim Ramsay; Dean Fergusson
Journal:  Trials       Date:  2012-08-16       Impact factor: 2.279

View more
  5 in total

Review 1.  Kidney cancer: Undertreatment of small renal masses by overuse of biopsy.

Authors:  Hiten D Patel; Phillip M Pierorazio
Journal:  Nat Rev Urol       Date:  2016-11-02       Impact factor: 14.432

Review 2.  Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.

Authors:  Hiten D Patel; Phillip M Pierorazio; Michael H Johnson; Ritu Sharma; Emmanuel Iyoha; Mohamad E Allaf; Eric B Bass; Stephen M Sozio
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-08       Impact factor: 8.237

3.  Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.

Authors:  Ridwan Alam; Hiten D Patel; Tijani Osumah; Arnav Srivastava; Michael A Gorin; Michael H Johnson; Bruce J Trock; Peter Chang; Andrew A Wagner; James M McKiernan; Mohamad E Allaf; Phillip M Pierorazio
Journal:  BJU Int       Date:  2018-08-09       Impact factor: 5.588

4.  The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Authors:  Hiten D Patel; Maneka Puligandla; Brian M Shuch; Bradley C Leibovich; Anil Kapoor; Viraj A Master; Charles G Drake; Daniel Yc Heng; Primo N Lara; Toni K Choueiri; Deborah Maskens; Eric A Singer; Scott E Eggener; Robert S Svatek; Walter M Stadler; Suzanne Cole; Sabina Signoretti; Rajan T Gupta; Marc Dror Michaelson; David F McDermott; David Cella; Lynne I Wagner; Naomi B Haas; Michael A Carducci; Lauren C Harshman; Mohamad E Allaf
Journal:  Future Oncol       Date:  2019-04-10       Impact factor: 3.404

Review 5.  Decision-making in active surveillance in kidney cancer: current trends and future urine and tissue markers.

Authors:  Sunil H Patel; Nirmish Singla; Phillip M Pierorazio
Journal:  World J Urol       Date:  2021-08-09       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.